PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Southern Community Laboratories, Dunedin, New Zealand; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.\', \'Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.\', \'Institute of Environmental Science and Research, Wellington, New Zealand.\', \'Department of Mathematics and Statistics, University of Otago, Dunedin, New Zealand.\', \'Labtests, Auckland, New Zealand; LabPlus, Auckland Hospital, Auckland, New Zealand.\', \'Public Health South, Southern District Health Board, Dunedin, New Zealand.\', \'Southern Community Laboratories, Dunedin, New Zealand. Electronic address: arlo.upton@sclabs.co.nz.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0031-3025(21)00228-210.1016/j.pathol.2021.04.001
?:doi
?:hasPublicationType
?:journal
  • Pathology
is ?:pmid of
?:pmid
?:pmid
  • 34119335
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.944
?:rankingScore_hIndex
  • 56
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all